相关实验视频
Updated: Jan 9, 2026

07:01
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
86.1K
低氧诱导因素与质母细胞瘤中亡之间的相互作用
Md Ataur Rahman1, Maroua Jalouli2, Mohammed Al-Zharani2
1Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA.
Biochemical pharmacology
|December 8, 2025
概括
质母细胞瘤 (GBM) 中的缺氧通过激活HIF转录因子来促进瘤生长和抵抗. 针对HIF-亡轴提供了一个有希望的策略,以克服GBM的治疗耐药性.
科学领域:
- 神经瘤学神经瘤学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 质母细胞瘤 (GBM) 呈现出低氧瘤微环境.
- 缺氧稳定了HIF-1α和HIF-2α,促进了GBM的进展和治疗耐药性.
- HIFs调解了诸如血管生成,代谢重编程和亡抵抗等适应性反应.
研究的目的:
- 审查HIF-亡轴在GBM中的作用.
- 讨论针对这一轴的治疗策略.
主要方法:
- 关于GBM研究近期进展的文献综述.
- 在质母细胞瘤中对HIF-亡交叉的分析.
主要成果:
- 缺氧诱导的HIF抑制了亲亡信号传递 (例如,p53) 并诱导了抗亡蛋白 (例如,Bcl-2,Bcl-xL).
- HIF-2α维持着类似于质母细胞的干细胞 (GSCs),有助于异质性和耐药性.
- HIF-亡轴对GBM生存和治疗耐药性至关重要.
结论:
- 准HIF-亡轴是GBM的一个有前途的治疗策略.
- 涉及低氧信号抑制剂和亡调节剂的组合疗法可以克服治疗耐药性.
相关概念视频
The Intrinsic Apoptotic Pathway
8.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Apoptosis
13.9K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
13.9K
The Extrinsic Apoptotic Pathway
8.0K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.0K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K

